Advertisement
News
Subscribe to MDT Magazine News

Plant-Based ‘Microswimmers’ Could Propel Drugs to the Right Location

December 19, 2013 3:24 pm | by American Chemical Society | Comments

In the quest to shrink motors so they can maneuver in tiny spaces like inside and between human cells, scientists have taken inspiration from millions of years of plant evolution and incorporated, for the first time, corkscrew structures from...

TOPICS:

pSivida, Alimera Sciences soar as Iluvien skips ahead to FDA review

December 19, 2013 1:58 pm | by Mass Device | Comments

Massachusetts-based pSivida is making a comeback, with shares soaring on news that the company and its licensee Alimera Sciences will get to skip past the advisory panel committee meeting and head straight to final FDA review for the Iluvien...

TOPICS:

Xlumena wins FDA nod for Axios pancreatic stent

December 19, 2013 1:54 pm | by Mass Device | Comments

Xlumena won FDA approval to market its Axios stent and delivery system, landing approval through the FDA's less-stringent de novo review pathway. The stent is the 1st specifically designed for the drainage of a pancreatic pseudocyst by creating...

TOPICS:
Advertisement

Short-seller takes another shot at Mindray Medical

December 19, 2013 1:41 pm | by Mass Device | Comments

Short-seller Ottoman Bay Research took another shot at Mindray Medical this week, taking issue with the Chinese medical device company's response to Ottoman's initial accusations of fraud and mismanagement. MR shares lost 11% Dec. 12 after...

Genstar Capital Announces Acquisition of Tecomet

December 19, 2013 1:40 pm | by The Associated Press | Tecomet | Comments

Genstar Capital Management, LLC, a middle market private equity firm that focuses on investments in selected segments of the industrial technology, healthcare, financial services, and software industries, announced today the acquisition of Tecomet...

Medifocus brings in $3.5M via debt financing

December 19, 2013 1:29 pm | by Mass Device | Comments

Medifocus said it brought in $3.5 million in a private offering of convertible debt, a raise tied to company's August non-brokered private placement of $6 million. The $3.5 million came from 354 redeemable promissory notes priced at $10,000...

World's First Implant After FDA Approval for Groundbreaking Epilepsy Treatment

December 19, 2013 12:39 pm | by The Associated Press | Comments

On Dec. 18, Keck Medicine of USC became the world's first medical center to implant a responsive brain device newly approved by the Food and Drug Administration (FDA) to treat epilepsy, with potential to help millions of people worldwide...

TOPICS:

ZipLine® Medical Clinical Study Data Presented at Mt. Sinai “Winter Symposium”: ZipLine Produces Suture-Like Outcomes with Significant Surgical Time-Savings

December 19, 2013 11:29 am | by Business Wire | Comments

Preliminary clinical study results from a randomized, controlled, prospective clinical study comparing the ZipLine Surgical Skin Closure to traditional stitches for skin cancer excision were presented at the 16th Annual Mount Sinai Winter Symposium...

TOPICS:
Advertisement

UCLA Researcher Highlights Advances in Nanotechnology's Fight Against Cancer

December 19, 2013 11:13 am | by University of California - Los Angeles | Comments

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application...

TOPICS:

Survey: Regulatory Agencies Viewed as Unprepared for Nanotechnology

December 19, 2013 11:06 am | by University of California - Santa Barbara | Comments

Three stakeholder groups agree that regulators are not adequately prepared to manage the risks posed by nanotechnology, according to a paper published in the peer-reviewed journal PLOS One. In a survey of nano-scientists and engineers...  

TOPICS:

Texting May Be Good for Your Health

December 19, 2013 11:02 am | by University of Michigan Health System | Comments

New University of Michigan research says that a simple tool right in your back pocket may help decrease your risk for type 2 diabetes: Text messages on your phone. An overwhelming majority of surveyed people who enrolled in customized texting...

TOPICS:

First Cancer Operation Room with a Navigator Is Created

December 19, 2013 10:59 am | by Universidad Carlos III de Madrid | Comments

A team of researchers from Gregorio Marañón Hospital, the company GMV and the Universidad Carlos III de Madrid (UC3M) have started the first cancer operation room with a navigator. This image-guided system will allow for increased intraoperative...

TOPICS:

Photo of the Day: Newly Designed Cancer OR

December 19, 2013 10:57 am | by Universidad Carlos III de Madrid | Comments

The system, presented at Gregorio Marañón Hospital, permits real-time interaction with the body of the patient (with its different tissues and cancer) as well as the radiotherapy applicator used to radiate the area affected by the tumor. This...

TOPICS:

Screening Device Differentiates Between Normal and Unhealthy Cells

December 19, 2013 10:48 am | by University of Surrey | Comments

A University of Surrey research team has developed an innovative device that can differentiate between normal and unhealthy cells. The team, led by Michael Hughes, Professor of Biomedical Engineering, has developed a device that analyzes the...

TOPICS:

USDM Life Sciences Hires FDA's Unique Device Identification Architect, Jay Crowley as Vice President of UDI Practice

December 19, 2013 10:39 am | by The Associated Press | Comments

USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, hires Jay Crowley as Vice President of the Unique Device Identification (UDI) practice. As Senior Advisor for Patient Safety in the Food and Drug...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading